NCT04480567
Phenylketonuria, Phenylketonuria (PKU)
The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.
This is a Phase 1/2, open-label, dose escalation study to evaluate the safety, efficacy and tolerability of BMN 307 in adult PKU subjects with PAH deficiency. Participants will receive a single administration of BMN 307 and will be followed for safety and efficacy.
All
From 15 Years
No
BMN 307
Phase 1/Phase 2
Interventional
100
2020-09-24
2024-12-12
Tampa, Florida, United States
Morristown, New Jersey, United States
Birmingham, , United Kingdom
*required fields
"*" indicates required fields